Safety and feasibility of the use of a bevacizumab-methylcellulose mixture as an adjunct to glaucoma surgery: a pilot study
ABSTRACT Bevacizumab, a monoclonal anti-vascular endothelial growth factor antibody, has been suggested as a potential healing therapeutic following glaucoma surgery. Here, we aimed to improve the bioavailability of bevacizumab when used as an adjunct therapy to non-penetrating deep sclerectomy (DS)...
Main Authors: | Jayter Silva Paula, Danilo José Lopes Secches, Marcelo Jordão Lopes Silva, Maria de Lourdes Veronese Rodrigues, Armando da Silva Cunha Junior |
---|---|
Format: | Article |
Language: | English |
Published: |
Conselho Brasileiro de Oftalmologia
2015-06-01
|
Series: | Arquivos Brasileiros de Oftalmologia |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27492015000300015&lng=en&tlng=en |
Similar Items
-
Omalizumab na urticária ao frio grave
by: Sara Dias Leite, et al.
Published: (2017-07-01) -
Use of rituximab as a treatment for systemic lupus erythematosus: retrospective review
by: Roberta Ismael Lacerda Machado, et al. -
Bone health in cerebral palsy and introduction of a novel therapy
by: Morton Aaron Scheinberg, et al. -
Enxerto de retalho escleral de doador como tratamento definitivo de maculopatia hipotônica pós trabeculectomia
by: Neilzo Nunes Oliveira, et al.
Published: (2016-04-01) -
Opções Terapêuticas Emergentes no Tratamento da Psoríase em Placas na Forma Moderada a Grave
by: Ana Sofia Figueiredo Alves, et al.
Published: (2016-10-01)